Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22945623 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
Condition: Opiate Dependence
Interventions: Drug: VIVITROL® 380 mg;   Drug: Placebo

Indicates status has not been verified in more than two years